Canadian pharmaceutical company H&P Labs, Inc., announced earlier this month a partnership with Harvard and the Brigham and Women’s Hospital dedicated to the development of a new drug to fight the Ebola virus. James Cunningham, associate professor of medicine, is the project’s head researcher.
